by Arjun Walia, Collective Evolution
Good news, reports indicate that a hospital in the US has finally begun using Vitamin C to treat coronavirus patients, and it looks like it’s working quite well. We were first turned on to vitamin C and the idea that it may help protect against this new coronavirus in February, when the US National Library of Medicine posted the information about their clinical trials on their website. The title of one of the trials is “Vitamin C Infusion for the Treatment of Severe 2019-nCoV Infected Pneumonia.” The sponsor is ZhiYong Peng, and the responsible party is Zhongnan Hospital in Wuhan University (ZNWU).
We came across some mainstream media outlets claiming that Vitamin C is extremely unlikely to help people fight off the new coronavirus. Like this one from LiveScience. They wrote it before becoming aware of the clinical trials taking place, and then updated their article to include that information. We felt it was important to continue covering this emerging story as it was inspiring and mainstream media was avoiding it and even misleading people.
That being said, it’s still quite clear via mainstream media that according to experts, there is no evidence that vitamin C does anything to help people with, or prevent the new coronavirus.
What we felt was important to reflect on was, if it’s true that vitamin C is extremely unlikely to help, why would critical resources be used at this time to start multiple clinical trials in China? Furthermore, why would we be getting updates from people like Dr. Richard Cheng, MD, PhD, a US board-certified specialist, stating that so far, they’ve seen a great deal of success with regards to treating coronavirus patients with intravenous vitamin C? According to Cheng, 50 moderate to severe cases of COVID-19 infection were treated with high-dose IVC. Dosing of IVC ranged from 10,000 – 20,000 mg a day for 7-10 days, with 10,000 mg for moderate cases and 20,000 for more severe cases. The first bit of good news was that all patients who received IVC improved and there has been no mortality. Secondly, as compared to the average of a 30-day hospital stay for all COVID-19 patients, those patients who received high dose IVC had a hospital stay of about 3-5 days shorter than the other patients.
© 2020 Collective Evolution